Monoclonal Gammopathy of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Monoclonal Gammopathy of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
This clinical trial update describes a study using integrative multi-omics analysis to predict the clinical evolution of monoclonal gammopat…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
An observational prospective study at MD Anderson Cancer Center investigating monoclonal gammopathies that progress to myeloma; the trial is…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
The document reports specimen collection activities for the Agricultural Health Study pesticide exposure cohort, a National Cancer Institute…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) [NA]
A clinical trial protocol comparing a plant-based diet with supplements and a placebo in people with Monoclonal Gammopathy of Undetermined S…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
A clinical trial in Italy (ProDigALIty) aims to promote diagnosis and management of AL amyloidosis and related plasma cell disorders and is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Pre-malignant States to Hematologic Malignancies in Firefighters
A Wake Forest trial investigates progression from pre-malignant hematologic states to blood cancers in firefighters and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
This clinical trial update notes a study recruiting to assess quality of life in patients with asymptomatic monoclonal gammopathies, includi…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
The document provides a clinical trial update from the University of Miami describing two distinct precursor states of multiple myeloma—prog…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 proof-of-concept trial assessing Linvoseltamab in adults with high-risk Monoclonal Gammopathy of Undetermined Significance or non-hi…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
This clinical trial update describes the MAGIC Screening Study, an enrolling-by-invitation program to screen for Monoclonal Gammopathy of Un…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clonal Hematopoiesis of Immunological Significance
This is a clinical trial update about clonal hematopoiesis of immunological significance (CHIS) sponsored by Assistance Publique - Hôpitaux …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
This document announces an ongoing registry and sample resource at Ohio State University Comprehensive Cancer Center for plasma cell dyscras…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
This clinical trial entry describes an ongoing study investigating how N-glycosylation contributes to AL amyloidosis, including its molecula…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease [NA]
This entry describes the FAST-M trial evaluating prolonged overnight fasting with a Mediterranean diet for patients with multiple myeloma or…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
A Dana-Farber Cancer Institute-led clinical study recruiting to investigate molecular progression and clinical outcomes in MGUS, smoldering …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study [NA]
A pilot clinical trial evaluating the effects of a Korean-style Mediterranean diet (KORMED) and physical activity measurement in patients wi…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
The CHAAMP internal pilot study is currently recruiting. It targets multiple myeloma and related plasma cell disorders, including MGUS and s…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells
Mayo Clinic reports a clinical trial investigating carbon-13–based deep labelling of bone marrow cells, currently enrolling by invitation fo…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: European Myeloma Network (EMN) Sample Project
A European Myeloma Network study evaluating treatment options for multiple myeloma and related plasma cell disorders is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) [NA]
A clinical trial is evaluating a plant-based diet and dietary supplements in people with smoldering multiple myeloma or monoclonal gammopath…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Sleep Apnea in Patients With MGUS and MM
This clinical trial update describes an ongoing study evaluating sleep apnea in patients with multiple myeloma and monoclonal gammopathy of …
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Iceland Screens, Treats or Prevents Multiple Myeloma [NA]
The Iceland iStopMM trial (NCT03327597) investigates screening, treatment, or prevention strategies to reduce progression from Monoclonal Ga…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program [NA]
This is a clinical trial update for a screening and patient navigation program aimed at early detection of multiple myeloma and related diso…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance
An ongoing prospective long-term observational study in patients with monoclonal gammopathy of undetermined significance (MGUS), sponsored b…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
A protocol to determine the frequency of variants in the GBA and PSAP genes among patients with monoclonal gammopathy of undetermined signif…